Author:
Dranitsaris George,Hatzimichael Eleftheria
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Carter JA, Snedecor SJ, Kaura S et al (2011) Cost-effectiveness of zoledronic acid versus denosumab in prevention of skeletal-related events in metastatic breast cancer. J Clin Oncol 29, suppl; abstr 9025
2. Clark JC, Dass CR, Choong PF (2008) Current and future treatments of bone metastases. Expert Opin Emerg Drugs 13:609–27
3. Coleman RE (2004) Bisphosphonates: clinical experience. Oncologist 9(Suppl 4):14–27
4. Delea T, McKiernan J, Brandman J et al (2006) Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol 4:341–7
5. Dranitsaris G, Truter I, Lubbe MS et al (2011) Advances in cancer therapeutics and patient access to new drugs. PharmacoEconomics 29:213–24
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献